跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
V-103
首页
药物
V-103
V-103
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Inhalable compositions for use in the treatment of pulmonary diseases
申请人: BREATH THERAPEUTICS GMBH
优先权: 2018
CN
US
WO
9 件公开
DENTAL CURABLE COMPOSITION HAVING GOOD COLOR COMPATIBILITY
申请人: KURARAY NORITAKE DENTAL INC
优先权: 2020
CN
EP
US
WO
4 件公开
Inhalable compositions comprising macrocyclic immunosuppressants
申请人: BREATH THERAPEUTICS GMBH
优先权: 2018
CN
US
WO
4 件公开
N PROTEIN EPITOPE MUTATION MARKER FOR PREPARING EPITOPE DELETION-MARKED VACCINE STRAIN OF TYPE II PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS (PRRSV) AND USE THEREOF
申请人: LANZHOU VETERINARY RES INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES
优先权: 2021
CN
US
WO
4 件公开
AEROSOL DEVICE BASED ON SEBUM-ABSORBING POWDER AND A PARTICULAR WATER-INSOLUBLE MINERAL COMPOUND
申请人: OREAL
优先权: 2013
US
Organic light-emitting device
申请人: CAMBRIDGE DISPLAY TECH LTD
优先权: 2014
US
低分子右旋糖酐牛黄酸和小球藻联合制备治疗皮肤相关疾病药物的应用
申请人: 中国药科大学
优先权: 2022
CN
COMPOSITIONS AND METHODS FOR DENTAL TISSUE ENGINEERING
申请人: JALILISADRABAD MARYAM
优先权: 2023
WO
药物
反馈